Detalhe da pesquisa
1.
Computational Chemistry in Structure-Based Solute Carrier Transporter Drug Design: Recent Advances and Future Perspectives.
J Chem Inf Model
; 64(5): 1433-1455, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294194
2.
Follistatin-like 1 (FSTL1) interacts with Wnt ligands and Frizzled receptors to enhance Wnt/ß-catenin signaling in obstructed kidneys in vivo.
J Biol Chem
; 298(7): 102010, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35525270
3.
Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors.
Acta Pharmacol Sin
; 42(8): 1354-1367, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33122823
4.
The binding mode of vilazodone in the human serotonin transporter elucidated by ligand docking and molecular dynamics simulations.
Phys Chem Chem Phys
; 22(9): 5132-5144, 2020 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073004
5.
Prediction of the binding mode and resistance profile for a dual-target pyrrolyl diketo acid scaffold against HIV-1 integrase and reverse-transcriptase-associated ribonuclease H.
Phys Chem Chem Phys
; 20(37): 23873-23884, 2018 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29947629
6.
Computational characterization of the selective inhibition of human norepinephrine and serotonin transporters by an escitalopram scaffold.
Phys Chem Chem Phys
; 20(46): 29513-29527, 2018 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30457616
7.
Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder.
Phys Chem Chem Phys
; 20(9): 6606-6616, 2018 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29451287
8.
Differentiating physicochemical properties between NDRIs and sNRIs clinically important for the treatment of ADHD.
Biochim Biophys Acta Gen Subj
; 1861(11 Pt A): 2766-2777, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28757337
9.
Revealing vilazodone's binding mechanism underlying its partial agonism to the 5-HT1A receptor in the treatment of major depressive disorder.
Phys Chem Chem Phys
; 19(42): 28885-28896, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29057413
10.
Discovery of novel 3-benzylquinazolin-4(3H)-ones as potent vasodilative agents.
Bioorg Med Chem Lett
; 24(24): 5597-5601, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25466182
11.
Targeting PI4KA sensitizes refractory leukemia to chemotherapy by modulating the ERK/AMPK/OXPHOS axis.
Theranostics
; 12(16): 6972-6988, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36276647
12.
Rational Remodeling of Atypical Scaffolds for the Design of Photoswitchable Cannabinoid Receptor Tools.
J Med Chem
; 64(18): 13752-13765, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34477367
13.
Selective Inhibition of HDAC1 by Macrocyclic Polypeptide for the Treatment of Glioblastoma: A Binding Mechanistic Analysis Based on Molecular Dynamics.
Front Mol Biosci
; 7: 41, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32219100
14.
Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters.
Curr Med Chem
; 27(23): 3830-3876, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-30306851
15.
Exploring the Binding Mechanism of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators in Clinical Trials by Molecular Dynamics Simulations.
ACS Chem Neurosci
; 9(6): 1492-1502, 2018 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29522307
16.
What Contributes to Serotonin-Norepinephrine Reuptake Inhibitors' Dual-Targeting Mechanism? The Key Role of Transmembrane Domain 6 in Human Serotonin and Norepinephrine Transporters Revealed by Molecular Dynamics Simulation.
ACS Chem Neurosci
; 9(5): 1128-1140, 2018 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29300091
17.
Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study.
Sci Rep
; 6: 26883, 2016 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27230580